Advances in Chemoprevention of Head and Neck Cancer

Advances in Chemoprevention of Head and Neck Cancer John C. Rhee, Fadlo R. Khuri, Dong M. Shin Oncologist 2004; 9: 302-311 Author Information and Disclosures Target Audience: Physicians who wish to advance their current knowledge of clinical cancer medicine in Head and Neck Cancers and are involved in providing patient care in a cancer care environment. Method of Physician Participation: Read course materials, complete course quiz and evaluation form (optional). Learning Objectives After completing this course, the reader should be able to: Describe the mechanism of carcinogenesis of head and neck cancer. Explain chemoprevention with retinoids and other chemopreventive compounds. Discuss the published data including phase II and phase III randomized trials. The NIH/FAES designates this educational activity for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

CME Activity Information Accreditation CME Instructions For Credit Privacy Statement Hardware/Software Requirements Release Date: May 28, 2004 Most Recent Review: May 28, 2004* Most Recent Update: May 28, 2004 Date Credit Expires: Apr. 10, 2007 Time to Complete: 1 hour Medium: Internet Online *Click here to learn more about our review process.